Alteration of hepatic glutathione peroxidase and superoxide dismutase expression in streptozotocin-induced diabetic mice by berberine

References

• Baynes JW. (1991). Role of oxidative stress in development of complications in diabetes. Diabetes, 40, 405–412.
   PubMed Web of Science ®Google Scholar
• Brownlee M. (2001). Biochemistry and molecular cell biology of diabetic complications. Nature, 414, 813–820.
   PubMed Web of Science ®Google Scholar
• Hammes HP, Bartmann A, Engel L, Wulfroth P. (1997). Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine. Diabetologia, 40, 629–634.
   PubMed Web of Science ®Google Scholar
• Hayashi K, Kojima R, Ito M. (2006). Strain differences in the diabetogenic activity of streptozotocin in mice. Biol Pharm Bull, 29, 1110–1119.
   PubMedGoogle Scholar
• Kakkar A, Mantha SV, RadhiJ, Prasad K. (1998). Increased oxidative stress in rat liver and pancreas during progression of streptozotocin-induced diabetes. Clin Sci, 94, 623–632.
   PubMed Web of Science ®Google Scholar
• King H, Aubert RE, Herman WH. (1998). Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care, 21, 1414–1431.
   PubMed Web of Science ®Google Scholar
• Kondo S, Chatuphonprasert W, Jaruchotikamol A, Sakuma T, Nemoto N. (2011). Cellular glutathione content modulates the effect of andrographolide on β-naphthoflavone-induced CYP1A1 mRNA expression in mouse hepatocytes. Toxicology, 280, 11–23.
   Google Scholar
• Lenzen S. (2007). The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia, 51, 216–226.
   Google Scholar
• Likidlilid A, Patchanans N, Poldee S, Peerapatdit T. (2007). Glutathione and glutathione peroxidase in type 1 diabetic patients. J Med Assoc Thailand, 90, 1759–1767.
   Google Scholar
• Li R, Coway DB, Mickle DAG, Weisel RD, Burton GW. (1996). Effect of vitamin E on human glutathione peroxidase (GSH-px1) expression in cardiomyocytes. Free Radical Biol Med, 21, 419–426.
   PubMed Web of Science ®Google Scholar
• Maritim AC, Sanders RA, Watkins JB. (2003). Diabetes, oxidative stress, and antioxidants: A review. Biochem Mol Toxicol, 17, 24–38.
   PubMed Web of Science ®Google Scholar
• Morel Y, Barouki R. (1999). Repression of gene expression by oxidative stress. Biochem J, 342, 481–496.
   PubMed Web of Science ®Google Scholar
• Mouatassim S, Guerin P, Menezo Y. (1999). Expression of genes encoding antioxidant enzymes in human and mouse oocytes during the final stages of maturation. Mol Human Reprod, 5, 720–725.
   Google Scholar
• Naso F, Dias AS, Porawski M, Marroni NAP. (2011). Exogenous superoxide dismutase: Action on liver oxidative stress in animals with streptozotocin-induced diabetes. Exper Diabetes Res, Article ID 754132, 1–6.
   Google Scholar
• Piconi L, Quagliaro L, Ceriello A. (2003). Oxidative stress in diabetes. Clin Chem Lab Med, 41, 1144–1149.
   PubMed Web of Science ®Google Scholar
• Pompella A, Visvikis A, Paolicchi A, Tata VD, Casini AF. (2003). The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol, 66, 1499–1503.
   PubMed Web of Science ®Google Scholar
• Robertson RP. (2004). Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem, 279, 42351–42354.
   PubMed Web of Science ®Google Scholar
• Rojsanga P, Gritsanapan W, Suntornsuk L. (2006). Determination of berberine content in the stem extracts of Coscinium fenestratum by densitometry. Med Princ Pract, 15, 373–378.
   Google Scholar
• Sakuma T, Honma R, Maguchi S, Tamaki H, Nemoto N. (2001). Different expression of hepatic and renal cytochrorne P450s between the streptozotocin-induced diabetic mouse and rat. Xenobiotica, 31, 223–237.
   PubMed Web of Science ®Google Scholar
• Srinivasan K, Ramarao P. (2007). Animal models in type 2 diabetes research: An overview. Indian J Med Res, 125, 451–472.
   PubMed Web of Science ®Google Scholar
• Sukenaga Y, Ishida K, Takeda T, Takagi K. (1987). Nucleotide sequence of a human gene for glutathione peroxidase. Nucl Acids Res, 15, 71–78.
   Google Scholar
• Szkudelski T. (2001). The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res, 50, 536–546
   Web of Science ®Google Scholar
• Tanaka Y, Gleason CE, Tran PO, Harmon JS, Robertson RP. (1999). Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci USA, 96, 10857–10862.
   PubMed Web of Science ®Google Scholar
• Tang LQ, Wei W, Chen LM, Liu S. (2006). Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. J Ethnopharmacol, 108, 109–115.
   PubMed Web of Science ®Google Scholar
• Ueno Y, Kizaki M, Nakagiri R, Kamiya T, Sumi H, Osawa T. (2002). Dietary glutathione protects rats from diabetic nephropathy and neuropathy. J Nutr, 32, 897–900.
   Google Scholar
• Wang Y, Campbell T, Perry B, Beaurepaire C, Qin L. (2010). Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats. Metabolism, 60, 298–305.
   Google Scholar
• West IC. (2000). Radicals and oxidative stress in diabetes. Diabetes Med, 17, 171–180.
   PubMed Web of Science ®Google Scholar
• Wild S, Roglic G, Green A, Sicree R, King H. (2004). Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care, 27, 1047–1053.
   PubMed Web of Science ®Google Scholar
• Wohaieb SA, Godin DV. (1987). Alterations in free radical tissue-defense mechanisms in streptozocin-induced diabetes in rat, effects of insulin treatment. Diabetes, 36, 1014–1018.
   PubMed Web of Science ®Google Scholar
• Wolff SP, Dean RT. (1987). Glucose autoxidation and protein modification. The potential role of ‘autoxidative glycosylation’ in diabetes. Biochem J, 245, 243–250.
   PubMed Web of Science ®Google Scholar
• Zelko IN, Mariani TJ, Folz RJ. (2002). Superoxide dismutase multigene family: A comparison of the Cuzn-Sod (Sod1), Mn-Sod (Sod2), and Ec-Sod (Sod3) gene structures, evolution, and expression. Free Radical Biol Med, 33, 337–349.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Xiao X, Feng K, Wang T, Li W, Yuan T, Sun X, Sun Q, Xiang H, Wang H. (2011). Berberine moderates glucose and lipid metabolism through multi pathway mechanism. Evid-Based Complement Alternat Med, 2011, 1–10.
   Google Scholar
• Zhang Y, Li X, Zou D, Liu W, Yang J, Zhu N, Huo L, Wang M, Hong J, Wu P, Ren G, Ning G. (2008). Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab, 93, 2559–2565.
   PubMed Web of Science ®Google Scholar